Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
2.48
Dollar change
+0.09
Percentage change
3.77
%
Index- P/E18.87 EPS (ttm)0.13 Insider Own43.91% Shs Outstand45.57M Perf Week7.83%
Market Cap113.01M Forward P/E10.60 EPS next Y0.23 Insider Trans0.00% Shs Float25.56M Perf Month3.77%
Income5.98M PEG- EPS next Q-0.01 Inst Own11.68% Short Float0.20% Perf Quarter2.06%
Sales117.93M P/S0.96 EPS this Y99.27% Inst Trans- Short Ratio0.98 Perf Half Y58.97%
Book/sh3.01 P/B0.82 EPS next Y8700.00% ROA2.64% Short Interest0.05M Perf Year45.88%
Cash/sh0.69 P/C3.60 EPS next 5Y- ROE4.37% 52W Range0.99 - 3.72 Perf YTD92.28%
Dividend Est.- P/FCF- EPS past 5Y-13.21% ROI3.61% 52W High-33.33% Beta0.94
Dividend TTM- Quick Ratio1.21 Sales past 5Y193.59% Gross Margin34.26% 52W Low150.51% ATR (14)0.15
Dividend Ex-Date- Current Ratio1.90 EPS Y/Y TTM-18.89% Oper. Margin7.56% RSI (14)55.84 Volatility5.03% 5.91%
Employees- Debt/Eq0.32 Sales Y/Y TTM17.85% Profit Margin5.07% Recom1.00 Target Price1.43
Option/ShortYes / Yes LT Debt/Eq0.21 EPS Q/Q-71.13% Payout- Rel Volume0.60 Prev Close2.39
Sales Surprise- EPS Surprise- Sales Q/Q-1.38% EarningsMay 13 Avg Volume52.67K Price2.48
SMA2012.04% SMA50-8.39% SMA20031.39% Trades Volume31,663 Change3.77%
Date Action Analyst Rating Change Price Target Change
May-18-22Upgrade Canaccord Genuity Speculative Buy → Buy $13
May-22-24 06:45AM
May-01-24 08:27AM
Apr-01-24 09:09AM
Mar-22-24 11:58AM
Feb-13-24 04:46PM
09:27AM Loading…
Jan-31-24 09:27AM
Oct-31-23 04:39PM
Oct-17-23 05:04PM
Aug-31-23 07:45PM
Jul-10-23 05:00PM
Jun-09-23 05:18PM
May-15-23 05:59PM
05:45PM
08:30AM
Apr-25-23 07:19PM
05:59PM Loading…
Apr-24-23 05:59PM
Apr-20-23 08:30AM
Apr-03-23 03:27PM
Mar-31-23 08:00PM
Feb-14-23 08:30AM
Feb-01-23 08:30AM
Dec-19-22 08:30AM
Dec-08-22 09:30AM
Dec-05-22 04:30PM
Nov-23-22 04:30PM
Nov-17-22 08:17AM
Nov-15-22 11:18AM
09:03AM
Nov-11-22 08:32AM
Sep-16-22 04:30PM
09:15AM Loading…
Aug-15-22 09:15AM
Aug-11-22 10:30AM
Jul-21-22 09:00AM
Jul-18-22 08:00AM
Jun-21-22 08:40AM
Jun-02-22 08:30AM
May-19-22 11:36AM
May-16-22 05:50PM
01:30AM
May-09-22 11:20AM
May-03-22 11:28AM
Apr-11-22 08:05PM
Apr-06-22 12:39AM
Apr-05-22 08:47AM
Apr-04-22 09:33AM
08:29AM
Apr-03-22 03:35AM
Mar-30-22 09:00AM
Mar-28-22 07:00AM
Mar-22-22 08:52AM
08:30AM
Mar-15-22 11:34AM
Mar-01-22 01:00AM
Feb-21-22 11:42AM
Feb-16-22 01:00AM
Feb-14-22 08:43PM
Feb-08-22 01:00AM
Feb-07-22 08:38PM
Dec-02-21 08:15AM
08:03AM
Nov-29-21 08:30AM
Nov-15-21 07:00PM
06:50PM
Nov-11-21 08:00AM
Oct-29-21 04:34PM
Oct-25-21 01:30AM
Oct-13-21 12:15PM
Oct-12-21 02:00AM
Sep-15-21 08:59AM
Sep-13-21 08:43AM
Sep-08-21 09:57AM
Sep-03-21 09:29AM
08:35AM
Sep-02-21 09:39AM
Sep-01-21 01:00AM
InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies in the Biomed Sector and Investments in the Medical Cannabis Sector segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.